Clinical trial

Cardiovascular Genistein Therapy for Heart Failure Inflammation

NCT06501768

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2024-07-01

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2024-07-01Date precision: day

Registry last updated2024-07-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failureunresolved

Interventions

GenisteinDRUG · verified · RxNorm: genistein

Sponsors & collaborators

University Medical Centre Ljubljanalead sponsor

Greenstone Biosciences, Inc.collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06501768 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.